Appropriate Blood Pressure in Cerebral Aneurysm Clipping for Prevention of Delayed Ischemic Neurologic Deficits

Table 1

Demographic data.

Characteristics	DNID	No DNID	value
Gender, N (%)			>0.99
Male	4 (28.6)	9 (32.1)
Female	10 (71.4)	19 (67.9)
Age (yrs) mean ± SD	57.4 ± 12.5	56.3 ± 11.4	0.765
Body weight (kg) mean ± SD	64.0 ± 11.0	57.3 ± 9.1	0.042
Height (cm) mean ± SD	160.8 ± 6.2	161.4 ± 5.6	0.751
Hematocrit (%) mean ± SD	38.1 ± 4.6	37.6 ± 6.4	0.825
Underlying disease, N (%)
Diabetes mellitus	1 (3.7)	3 (75.0)	0.250
Hypertension	5 (18.5)	6 (22.2)	0.455
Cardiovascular disease	2 (7.4)	0	0.106
Others	2 (7.4)	8 (29.6)	>0.99
WFNS, N (%)			>0.99
1	5 (10.4)	10 (20.8)
2	3 (6.3)	6 (12.5)
3	0	0
4	6 (12.5)	12 (25.0)
5	0	0
FS, N (%)			>0.99
1	0	0
2	0	0
3	6 (12.5)	12 (25.0)
4	8 (16.7)	16 (33.3)
General anesthesia technique, N (%)			>0.99
Sevoflurane-based	2 (4.2)	4 (8.3)
Propofol-based	11 (22.9)	22 (45.8)
Mixed techniques	1 (2.1)	2 (4.2)
Estimated blood loss (cc)	721.4 ± 352.9	445.4 ± 172.1	0.008
Fluid resuscitation (cc), mean ± SD
Normal saline	1948.6 ± 739.0	2080.0 ± 723.0	0.406
Colloid	812.5 ± 541.0	464.5 ± 252.2	0.124
Packed red blood cells	2.7 ± 1.1	1.8 ± 0.9	0.045
Fresh frozen plasma	2.2 ± 1.0	1.8 ± 1.3	0.607
Medical resuscitation, mean ± SD
Ephedrine	18.0 ± 17.0	14.4 ± 8.7	0.925
Levophed	16.0 ± 10.6	26.9 ± 16.3	0.327
Nicardepine	2.5 ± 2.1	0.9 ± 0.2	0.221
Herbesser	5.0 ± 2.7	8.5 ± 5.1	0.332
Esmolol	37.0 ± 19.9	61.7 ± 76.5	0.635
Labetelol	13.3 ± 2.9	45.0 ± 28.3	0.076
Temporary occlusion during surgery, N (%)	6 (42.9)	9 (32.1)	0.499
Duration of temporary occlusion (min), mean ± SD	3.8 ± 6.4	1.6 ± 3.4	0.159